LinkedIn Profile

Access ASLAN Pharmaceuticals historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:aslanpharma 1031515 Nov 18th, 2019 12:00AM ASLAN Pharmaceuticals 2.4K 35.00 Open Pharmaceuticals Nov 18th, 2019 03:45PM Nov 18th, 2019 03:45PM ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLAN is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL. Open oncology, Drug development, Licensing, Clinical development, Partnering, Biotechnology Open 83 Clemenceau Avenue, #12-03, UE Square Singapore SG 239920 ASLAN Pharmaceuticals
private:aslanpharma 1031515 Nov 16th, 2019 12:00AM ASLAN Pharmaceuticals 2.4K 36.00 Open Pharmaceuticals Nov 16th, 2019 03:57PM Nov 16th, 2019 03:57PM ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLAN is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL. Open oncology, Drug development, Licensing, Clinical development, Partnering, Biotechnology Open 83 Clemenceau Avenue, #12-03, UE Square Singapore SG 239920 ASLAN Pharmaceuticals
private:aslanpharma 1031515 Nov 15th, 2019 12:00AM ASLAN Pharmaceuticals 2.4K 36.00 Open Pharmaceuticals Nov 15th, 2019 12:38PM Nov 15th, 2019 12:38PM ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLAN is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL. Open oncology, Drug development, Licensing, Clinical development, Partnering, Biotechnology Open 83 Clemenceau Avenue, #12-03, UE Square Singapore SG 239920 ASLAN Pharmaceuticals
private:aslanpharma 1031515 Nov 14th, 2019 12:00AM ASLAN Pharmaceuticals 2.4K 36.00 Open Pharmaceuticals Nov 14th, 2019 05:54PM Nov 14th, 2019 05:54PM ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLAN is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL. Open oncology, Drug development, Licensing, Clinical development, Partnering, Biotechnology Open 83 Clemenceau Avenue, #12-03, UE Square Singapore SG 239920 ASLAN Pharmaceuticals
private:aslanpharma 1031515 Nov 13th, 2019 12:00AM ASLAN Pharmaceuticals 2.4K 37.00 Open Pharmaceuticals Nov 13th, 2019 01:06PM Nov 13th, 2019 01:06PM ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLAN is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL. Open oncology, Drug development, Licensing, Clinical development, Partnering, Biotechnology Open 83 Clemenceau Avenue, #12-03, UE Square Singapore SG 239920 ASLAN Pharmaceuticals
private:aslanpharma 1031515 Nov 12th, 2019 12:00AM ASLAN Pharmaceuticals 2.4K 37.00 Open Pharmaceuticals Nov 12th, 2019 02:48PM Nov 12th, 2019 02:48PM ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLAN is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL. Open oncology, Drug development, Licensing, Clinical development, Partnering, Biotechnology Open 83 Clemenceau Avenue, #12-03, UE Square Singapore SG 239920 ASLAN Pharmaceuticals
private:aslanpharma 1031515 Nov 11th, 2019 12:00AM ASLAN Pharmaceuticals 2.4K 37.00 Open Pharmaceuticals Nov 11th, 2019 02:46PM Nov 11th, 2019 02:46PM ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLAN is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL. Open oncology, Drug development, Licensing, Clinical development, Partnering, Biotechnology Open 83 Clemenceau Avenue, #12-03, UE Square Singapore SG 239920 ASLAN Pharmaceuticals
private:aslanpharma 1031515 Nov 10th, 2019 12:00AM ASLAN Pharmaceuticals 2.4K 37.00 Open Pharmaceuticals Nov 10th, 2019 05:53PM Nov 10th, 2019 05:53PM ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLAN is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL. Open oncology, Drug development, Licensing, Clinical development, Partnering, Biotechnology Open 83 Clemenceau Avenue, #12-03, UE Square Singapore SG 239920 ASLAN Pharmaceuticals
private:aslanpharma 1031515 Nov 9th, 2019 12:00AM ASLAN Pharmaceuticals 2.4K 37.00 Open Pharmaceuticals Nov 9th, 2019 05:20PM Nov 9th, 2019 05:20PM ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLAN is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL. Open oncology, Drug development, Licensing, Clinical development, Partnering, Biotechnology Open 83 Clemenceau Avenue, #12-03, UE Square Singapore SG 239920 ASLAN Pharmaceuticals
private:aslanpharma 1031515 Nov 8th, 2019 12:00AM ASLAN Pharmaceuticals 2.4K 37.00 Open Pharmaceuticals Nov 8th, 2019 02:31PM Nov 8th, 2019 02:31PM ASLAN Pharmaceuticals (ASLAN, 6497.TT) is a clinical-stage oncology-focused biopharmaceutical company developing novel therapeutics for global markets. ASLAN targets diseases that are both highly prevalent in Asia and orphan indications in the United States and Europe. Led by a senior management team with extensive experience in global and regional development and commercialization, ASLAN is headquartered in Singapore and has offices in Taiwan and China. ASLAN’s portfolio is comprised of four product candidates which target validated growth pathways applied to new patient segments, novel immune checkpoints and novel cancer metabolic pathways. ASLAN’s partners include Array BioPharma, Bristol-Myers Squibb, Almirall and CSL. Open oncology, Drug development, Licensing, Clinical development, Partnering, Biotechnology Open 83 Clemenceau Avenue, #12-03, UE Square Singapore SG 239920 ASLAN Pharmaceuticals

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.